Scholarly Index
John R. Mascola
National Institute of Allergy and Infectious Diseases; 80,412 total citations; 663 total publications; best world rank #8
National Institute of Allergy and Infectious Diseases
80,412Total citations
663Total publications
150H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Virology | Lifetime | 11 | US 10 | 99.87 |
| Infectious Diseases | Lifetime | 661 | US 341 | 97.21 |
| Immunology | Lifetime | 861 | US 437 | 97.17 |
| Virology | 2021-2025 | 62 | US 30 | 89.20 |
| Infectious Diseases | 2021-2025 | 451 | US 179 | 90.62 |
| HIV Research and Treatment | Lifetime | 8 | US 7 | 99.94 |
| Immune Cell Function and Interaction | Lifetime | 128 | US 82 | 99.82 |
| vaccines and immunoinformatics approaches | Lifetime | 23 | US 15 | 99.55 |
| HIV/AIDS drug development and treatment | Lifetime | 75 | US 43 | 99.55 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 340 | US 210 | 99.35 |
| Herpesvirus Infections and Treatments | Lifetime | 236 | US 158 | 98.55 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 436 | US 162 | 98.51 |
| Virology and Viral Diseases | Lifetime | 221 | US 115 | 97.93 |
| T-cell and B-cell Immunology | Lifetime | 916 | US 461 | 98.44 |
| Cytomegalovirus and herpesvirus research | Lifetime | 553 | US 317 | 97.68 |
| HIV Research and Treatment | 2021-2025 | 202 | US 96 | 95.47 |
| HIV/AIDS drug development and treatment | 2021-2025 | 475 | US 152 | 88.49 |
| Viral Infections and Outbreaks Research | 2021-2025 | 828 | US 239 | 79.22 |